David S. Silberstein's most recent trade in Lantern Pharma Inc was a trade of 25,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lantern Pharma Inc | David S. Silberstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Lantern Pharma Inc | David S. Silberstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 17,307 | 17,307 | - | - | Stock Option (Right to Buy) | |
| Lantern Pharma Inc | David S. Silberstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2025 | 9,135 | 9,135 | - | - | Stock Option (Right to Buy) | |
| Lantern Pharma Inc | David S. Silberstein | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Sep 2025 | 9,135 | 0 | - | - | Stock Option (Right to Buy) | |
| Lantern Pharma Inc | David S. Silberstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2025 | 3,200 | 3,200 | - | - | Stock Option (Right to Buy) | |
| Lantern Pharma Inc | David S. Silberstein | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Sep 2025 | 3,200 | 0 | - | - | Stock Option (Right to Buy) | |
| Lantern Pharma Inc | David S. Silberstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Lantern Pharma Inc | David S. Silberstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Lantern Pharma Inc | David S. Silberstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 3,200 | 3,200 | - | - | Stock Option (Right to Buy) |